KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 149 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $51,565 | -57.4% | 28,807 | -7.3% | 0.00% | -100.0% |
| Q1 2023 | $120,940 | +75.5% | 31,090 | +53.4% | 0.00% | 0.0% |
| Q4 2022 | $68,908 | -35.0% | 20,267 | +4.3% | 0.00% | 0.0% |
| Q3 2022 | $106,000 | +27.7% | 19,423 | +5.1% | 0.00% | 0.0% |
| Q2 2022 | $83,000 | -38.5% | 18,474 | +0.5% | 0.00% | 0.0% |
| Q1 2022 | $135,000 | +14.4% | 18,379 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $118,000 | +24.2% | 18,288 | +11.8% | 0.00% | 0.0% |
| Q3 2021 | $95,000 | -43.1% | 16,364 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $167,000 | +5.7% | 16,230 | +8.2% | 0.00% | 0.0% |
| Q1 2021 | $158,000 | -31.6% | 14,998 | +0.5% | 0.00% | -50.0% |
| Q4 2020 | $231,000 | +2.7% | 14,916 | -3.4% | 0.00% | 0.0% |
| Q3 2020 | $225,000 | +14.8% | 15,444 | +49.1% | 0.00% | -33.3% |
| Q2 2020 | $196,000 | -13.7% | 10,356 | -12.2% | 0.00% | -25.0% |
| Q1 2020 | $227,000 | – | 11,793 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,827,078 | $82,205,000 | 4.43% |
| Palo Alto Investors LP | 4,663,324 | $79,416,000 | 3.21% |
| Private Capital Advisors, Inc. | 473,901 | $8,071,000 | 2.23% |
| DOHENY ASSET MANAGEMENT /CA | 215,445 | $3,669,000 | 1.92% |
| Sandia Holdings, LLC | 119,739 | $2,039,000 | 0.96% |
| Capital Impact Advisors, LLC | 102,006 | $1,744,000 | 0.60% |
| Birchview Capital, LP | 50,000 | $852,000 | 0.55% |
| EMERALD ADVISERS, LLC | 694,068 | $11,820,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 647,307 | $11,024,000 | 0.37% |
| Schonfeld Strategic Advisors LLC | 418,100 | $7,121,000 | 0.32% |